I'm LongbridgeAI, I can summarize articles.LBPMedicin announced a shareholder inquiry transfer plan, with shareholders including Zhuji Gaotejia and others intending to transfer a total of 2% of the company's shares, totaling 1.8715 million shares. The shareholders participating in this inquiry transfer include Zhuji Gaotejia, Chongqing Gaotejia, Hangzhou Gaotejia, and Hangzhou Ruihong
According to the Zhitong Finance APP, LBPMedicin (688393.SH) has released a shareholder inquiry transfer plan. The shareholders participating in this inquiry transfer (hereinafter referred to as "this inquiry transfer") before the initial public offering of LBPMedicin are Zhuji Gaotejia Ruian Investment Partnership (Limited Partnership) (hereinafter referred to as "Zhuji Gaotejia"), Chongqing Gaotejia Ruian Equity Investment Fund Partnership (Limited Partnership) (hereinafter referred to as "Chongqing Gaotejia"), Hangzhou Gaotejia Ruihai Investment Partnership (Limited Partnership) (hereinafter referred to as "Hangzhou Gaotejia"), and Hangzhou Ruihong Investment Partnership (Limited Partnership) (hereinafter referred to as "Hangzhou Ruihong"). The transferor intends to transfer a total of 1.8715 million shares, accounting for 2.00% of the total share capital of LBPMedicin